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Abstract
Background: Verbal autopsy (VA) is a widely used method for analyzing cause of death in absence of vital
registration systems. We adapted the InterVA method to extrapolate causes of death for stillbirths and neonatal
deaths from verbal autopsy questionnaires, using data from Malawi, Zimbabwe, and Nepal.
Methods: We obtained 734 stillbirth and neonatal VAs from recent community studies in rural areas: 169 from
Malawi, 385 from Nepal, and 180 from Zimbabwe. Initial refinement of the InterVA model was based on 100
physician-reviewed VAs from Malawi. InterVA indicators and matrix probabilities for cause of death were reviewed
for clinical and epidemiological coherence by a pediatrician-researcher and an epidemiologist involved in the
development of InterVA. The modified InterVA model was evaluated by comparing population-level cause-specific
mortality fractions and individual agreement from two methods of interpretation (physician review and InterVA) for
a further 69 VAs from Malawi, 385 from Nepal, and 180 from Zimbabwe.
Results: Case-by-case agreement between InterVA and reviewing physician diagnoses for 69 cases from Malawi,
180 cases from Zimbabwe, and 385 cases from Nepal were 83% (kappa 0.76 (0.75 - 0.80)), 71% (kappa 0.41(0.32-
0.51)), and 74% (kappa 0.63 (0.60-0.63)), respectively. The proportion of stillbirths identified as fresh or macerated by
the different methods of VA interpretation was similar in all three settings. Comparing across countries, the
modified InterVA method found that proportions of preterm births and deaths due to infection were higher in
Zimbabwe (44%) than in Malawi (28%) or Nepal (20%).
Conclusion: The modified InterVA method provides plausible results for stillbirths and newborn deaths, broadly
comparable to physician review but with the advantage of internal consistency. The method allows standardized
cross-country comparisons and eliminates the inconsistencies of physician review in such comparisons.
Background
Cause-specific mortality data on childhood deaths are
vital to identify health needs, compare patterns of death
across populations, plan and monitor interventions, and
inform policy [1-3]. In high-income countries, all births
and deaths are enumerated through vital registration
systems, and death certification is routine. In low-
income settings, most births and deaths occur at home,
death certificates are rarely available, and vital registra-
tions are often inadequate or nonexistent [2-4].
Verbal autopsies (VAs) provide an alternative means
of identifying probable causes of death through inter-
views with a close caregiver of the deceased, in which
information about the circumstances, signs, and symp-
toms leading to death are gathered. VAs have limita-
tions: they require recollection of events at the time of
death, rely on understanding and reporting of signs and
symptoms by interviewees, and may be influenced by
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establish a diagnosis [5]. Conventionally, VA question-
naires are read by two or more physicians separately
and one or more causes of death are attributed. A cause
of death is established when physicians’ opinions corre-
spond; otherwise diagnosis is reconsidered and discussed
with or without the input of an additional physician. If
no agreement is reached, the cause of death is consid-
ered undetermined. Repeatability of this diagnostic pro-
cess over time and in different settings is problematic,
particularly when diagnostic criteria are not standar-
dized amongst different clinicians [6-8]. In some situa-
tions, disagreement between physicians is such that a
large proportion of causes of death remain indetermi-
nate [7,9]. Moreover, the method is costly, time-con-
suming, and requires the involvement of physicians who
are an already overstretched resource in low-income
countries [6,10].
Despite these limitations, VAs are useful in estimating
cause-specific mortality fractions (CSMFs) in population
studies [6,8,11]. They have been used extensively in epi-
demiological studies, household surveys, and sentinel
surveillance sites, and have been piloted in subsamples
from sample registration systems. There remains a need
to refine the technique to make it more comparable,
repeatable, easy to apply, and cost-effective.
VA questionnaires devised by the WHO attempt to
standardize the interview process, but more standar-
dized approaches to interpreting VA data are needed.
Hierarchical algorithms and computer programs based
on logistic regression have been used, but they are diffi-
cult to standardize across cultures and age groups and
can usually only identify single causes of death [12,13].
InterVA uses a probabilistic method and has been tested
in a range of settings for deaths at all ages, across sexes,
and for maternal deaths [14,15].
We describe the refinement and evaluation of InterVA
to identify causes of death in the perinatal (stillbirths
and neonatal deaths in the first seven days) and neonatal
periods, using data from three different settings: Malawi,
Zimbabwe, and Nepal.
Methods
Based on Bayes’ theorem [16], the InterVA model calcu-
lates the probability of a set of causes of death given the
presence of circumstances, signs, and symptoms (collec-
tively called ‘indicators’) reported in VA interviews. The
method is described in detail elsewhere [10,17]. Briefly,
a finite number of causes of death are assigned to a pre-
defined matrix of estimated probabilities of occurrence.
The presence of indicators (Table 1) modifies the prede-
fined probabilities of each cause of death upward or
downward using Bayes’ theorem according to the for-
mula
p(C|I) =
p(I|C) ∗ p(C)
p(I|C) ∗ p(C) +p (I|!C) ∗ p(!C)
where p (C|I) indicates the probability of a cause of
death (C) given the presence of the indicator (I) and p
(I/!C) is the probability of I in the absence of C [10].
Probabilities of final-cause categories increase or
decrease in relation to specific signs and symptoms
reported in the VA interview. If symptoms are not
reported, the probabilities do not change. The program
is available online http://www.InterVA.net. Users can
enter the data as single cases or in batches, and the
model generates up to three causes of death and their
respective likelihoods. Prior to the current study, the
probability matrix consisted of 34 cause of death classifi-
cations and 104 indicators [10].
Data sources
To explore the performance of InterVA in different set-
tings, 734 stillbirth and neonatal VAs were obtained
from rural areas of three low-income countries.
In Malawi (Mchinji District), 169 stillbirth and neona-
tal VAs were collected from 2004 to 2005, as part of a
cluster-randomized study evaluating two community
interventions to improve maternal and child health [18].
Although designed for the study, the VA questionnaire
was comparable in structure and content with the sub-
sequent WHO questionnaire [19]. Completed question-
naires were interpreted independently by two Malawian
pediatricians, who assigned up to three causes of death
on the basis of a hierarchical classification and algorithm
[ 2 0 ] .T h e yw e r ea b l et ou s ea l t e r n a t i v ed i a g n o s e sw h e r e
necessary. Discrepancies were resolved by discussion
and, if consensus could not be reached, the cause of
death was recorded as indeterminate.
In Nepal (Makwanpur district), 385 VAs were collected
from 2001 to 2003 as part of a cluster-randomized study
of a community intervention to improve maternal and
child health [21]. The questionnaire was again compar-
able with the subsequent WHO tool. Questionnaires
were interpreted independently by two Nepalese pediatri-
cians, who each assigned a single cause of death on the
basis of the same algorithm used in Malawi. Discrepan-
cies were resolved after review by a third physician.
The third data source included 180 neonatal deaths
from Zimbabwe, identified as part of a maternal and
perinatal mortality study conducted in 2007 and 2008
[22]. Neonatal VAs were conducted using the WHO
tool. Questionnaires were interpreted independently by
two physicians, who each assigned a single cause of
death using the International Classification of Diseases
and Related Health Problems (ICD-10). Discrepancies
were resolved after review by a third physician (Table 2).
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Indicators Cause of Death Categories
was this an elder 65+ years any chronic/recurrent diarr (4+w) Perinatal asphyxia
was this an adult 50-64 years any abdominal swelling Congenital malformation
was this a female 15-49 years any vomiting Prematurity
was this a male 15-49 years any yellowness/jaundice Tetanus
was this a child 5-14 years any abnormality of urine Pneumonia
was this a child 1-4 years any urinary retention Malaria
was this an infant 4 wks-1 yr any haematuria Measles
was this a neonate < 4 wks any swelling of ankles/legs Meningitis
was she pregnant at death no bilateral swelling of ankle Diarrhea
did pregnancy end within 6 weeks any skin lesions/ulcers Bloody diarrhea
did final illness last at least 3 weeks any rash (non-measles) Other acute infection
did final illness last < 3 weeks any herpes zoster Malnutrition
was death very sudden/unexpected any measles rash Kwashiorkor
was death during wet season any excessive night sweats HIV/AIDS related
was death during dry season any excessive water intake Pulmonary tuberculosis
was s/he in a transport accident any excessive urination Chronic infection
did s/he drown any excessive food intake Maternal causes
had s/he fallen recently any acute fever Acute respiratory disease (not pnem.)
any poisoning, bite, sting any persistent fever (> 2 wk) Chronic respiratory disease
was s/he a known smoker any enlarged/swollen glands Acute cardiac
any obvious recent injury any facial swelling Chronic cardiac
was s/he known to drink alcohol was there a coma > 24 hrs Stroke
any suggestion of homicide any weight loss Diabetes
any convulsions or fits any anaemia/paleness Malignancy
any diagnosis of epilepsy any drowsiness Liver disease
was the fontanelle raised any delayed/regressed development Kidney disease
was the fontanelle or eyeball sunken any diagnosis of asthma Disorders of the digestive system
any headache any diagnosis of diabetes Diseases of the nervous system
was there paralysis on both sides any diagnosis of heart disease Sickle cell anemia
any paralysis/weakness on 1 side any diagnosis of HIV/AIDS Transport-related accident
any stiff neck any diagnosis of hypertension Accidental poisoning
any oral candidiasis been discharged from hospital very ill Accidental drowning
any rigidity/lockjaw any suggestion of suicide Other accident
abnormal hair coloring any surgery just before death Homicide
any coughing with blood any diagnosis of TB Suicide
any chest pain was s/he adequately vaccinated
was there a cough for > 3 wks any diagnosis of liver disease Additional indicators
was there a cough for up to 3 wks any diagnosis of cancer did baby have arched back after 2 days
any productive cough any diagnosis of stroke baby stopped sucking after day 3
any rapid breathing any diagnosis of measles did the baby die on day 1
any breathlessness on exertion any diagnosis of kidney disease did the mother fail to receive tetanus toxoid vaccine
any breathlessness lying flat any diagnosis of hemoglobinopathy did convulsions happen on day 1
any chest indrawing any diagnosis of malaria was there no cry/move/breath at birth
any difficulty breathing any delivery complications was baby’s skin puffy/mushy at birth
any breast lump or lesion any heavy bleeding around delivery did the baby fail to cry at birth
any wheezing was there prolonged labor > 24 hrs
any cyanosis were there convulsions during delivery
any abdominal mass was the baby born early < 34 wks Additional causes of death
any abdominal pain was the baby small < 2500 g Fresh stillbirth
any diarrhea with blood was there difficulty breathing at birth Macerated stillbirth
any vomiting with blood any congenital malformations
any acute diarrhea (< 2 wks) was this a multiple birth
any persistent diarrhea (2-4 wks) any umbilical infection
Indicators added following refinement of InterVA for neonatal deaths are highlighted in bold.
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Initial refinement of the InterVA model was based on
100 (59%) physician-reviewed VAs from Malawi. The
use of these data for refinement was pragmatic in that,
at the time of refinement, they were the only data avail-
able. Data from the VA questionnaire were entered in
the InterVA model, which assigned causes of death and
associated likelihoods. The open histories, where the
caregiver reported the events leading to death, were
coded and also entered in the model. CSMFs obtained
using the original InterVA and physician review were
compared. CSMFs were calculated from the InterVA
output as the sum of the likelihoods computed for each
single cause of death category, divided by the sum of
the likelihoods for all causes. For the calculation of
CSMFs from physician-review data, if more than one
cause of death was assigned, each was considered as a
proportion of the total death. Therefore, if a single
cause of death was assigned by all physicians, or if only
one was available, it explained 100% of that death. If
more than one cause of death was attributed, each con-
tributed an equal proportion of the total 100%. For
example, if both reviewing physicians assigned prema-
turity as a cause of death and one of them also assigned
sepsis, then prematurity contributed 75% and sepsis 25%
to the death. In this way, every available physician diag-
nosis contributed to the cause-specific mortality profile,
avoiding a potential loss of information and bias that
might have been introduced by using consensus diag-
noses alone.
Fifty-four neonatal-death questionnaires were analyzed
with the original InterVA model. Stillbirths were initially
excluded, as InterVA was not designed to classify them.
The results of this first analysis identified the need for
greater differentiation in the model among causes of
death in the neonatal period. The InterVA indicators
and matrix probabilities were therefore reviewed for
clinical and epidemiological coherence by a pediatrician-
researcher (SV) and an epidemiologist involved in the
development of InterVA (EF). Following this initial
refinement, InterVA was evaluated by comparing case-
by-case diagnoses with physician-assigned diagnoses for
the same 100 VA cases, as well the population-level
CSMFs. A process of refinement and comparisons with
physician review was undertaken until InterVA elicited
mortality profiles deemed by the researchers to be plau-
sible and satisfactorily comparable to physician review.
Evaluating the refined InterVA model
The modified InterVA model was evaluated by compar-
ing population-level CSMFs derived from the two meth-
ods of interpretation (physician review and InterVA) for
a further and hitherto-untouched 69 VAs from Malawi,
385 from Nepal, and 180 from Zimbabwe. A diversity of
data sources was chosen to assess the performance of
InterVA in a range of settings. Comparisons of popula-
tion-level CSMFs were considered paramount as
InterVA is intended as a public health tool for health
monitoring and program evaluation, rather than for use
in clinical settings. Nevertheless, individual level, case-
by-case comparisons between physician diagnoses and
InterVA were also conducted and the kappa statistic for
interrater agreement was calculated to further evaluate
the InterVA against the only available alternative
method in our populations [23].
Ethical considerations
The Maimwana study (Malawi) received ethical approval
from the Malawi National Health Sciences Research
Committee; the MIRA Makwanpur, Nepal, study was
approved by the Nepal Health Research Council and the
Institute of Child Health and Great Ormond Street Hos-
pital ethics committees; and the Zimbabwe Maternal
and Perinatal Mortality Study received ethical approval
from the Medical Research Council of Zimbabwe
(MRCZ/A/1368).
Table 2 Characteristics of the three studies used as data sources
Malawi Nepal Zimbabwe
Neonatal mortality
rate
27/1000[30]. 33/1000[31] 24/1000[32]
Study period 1 year 3 years 2 years
Number of VA
questionnaires
169 385 180
Questionnaire Mixed open and closed questions Mixed open and closed
questions
Standard WHO tool incorporating open and closed
questions (24)
Interviewers 5 lay Malawian interviewers with
secondary education
Lay local field
coordinators
45 midwife enumerators
Physician review 2 experienced local pediatricians
Predefined algorithm
3 causes of death
3 experienced local
pediatricians
Predefined algorithm
1 cause of death
3 experienced local physicians
International Classification of Diseases and Related
Health Problems (ICD-10)
1 cause of death
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Refining InterVA
InterVA was modified to include two extra cause of
death categories: fresh stillbirth and macerated stillbirth.
To define the stillbirth diagnoses and differentiate
among possible causes of stillbirth and neonatal death,
nine further indicators were added to the model. The
resulting modifications to the specific indicators and
cause of death categories included in InterVA are
shown in Table 1. As these are extra entities in the
model, they run in parallel to the existing indicators and
causes without directly affecting them.
To compare the InterVA output and physician diagnoses
in the three settings, some rationalization between the phy-
sician-assigned causes and the causes obtained from
InterVA was necessary; therefore, causes of death not
included in the InterVA classification were grouped as
“other.” Similarly, infectious causes of neonatal deaths,
including sepsis, pneumonia, and meningitis were grouped
together into an “infection” category, since the possibilities
of clinically distinguishing them in newborn infants is diffi-
cult. There were no cases of neonatal tetanus. The resulting
CSMFs for InterVA and physician review of the 100 VA
cases from Malawi used to refine the model are shown in
Figure 1. In 73% of cases, at least one of the InterVA diag-
noses agreed with at least one of the physician diagnoses
(kappa 0.60 (95% confidence interval [CI]: 0.57, 0.70)).
Evaluation of the Refined InterVA Model
After refining the model, case-by-case agreement
between InterVA and reviewing physician diagnoses, for
69 cases from Malawi, 180 cases from Zimbabwe, and
385 cases from Nepal, was 83% (kappa 0.76 (0.75 -
0.80)), 71% (kappa 0.41(0.32-0.51)), and 74% (kappa 0.63
(0.60-0.63)), respectively.
CSMFs derived from InterVA and physician review in
Malawi, Zimbabwe, and Nepal are illustrated in Table 3.
In Malawi and Zimbabwe, the rank order of causes of
death was identical when derived from InterVA or physi-
cian review. In Nepal, the most common cause of death
according to InterVA was perinatal asphyxia, while it was
neonatal infections according to physicians. Prematurity
was diagnosed more commonly by InterVA than by phy-
sicians in Nepal and Zimbabwe. InterVA detected a
higher proportion of neonatal infections than physicians
in Zimbabwe, but a lower proportion in Nepal.
Stillbirths
The proportion of total stillbirths identified by the two
methods of VA interpretation was similar in all three
settings. Data from Malawi and Nepal allowed for a
more detailed comparison of the relative proportions of
fresh and macerated stillbirths (Table 4).
Multicountry mortality comparison
Considering the above evaluations and taking the
refined model to be adequate for the purposes of char-
acterizing cause compositions of neonatal mortality for
population health planning and monitoring, a three-
country comparison of neonatal cause-specific mortality
was conducted (Figure 2). It showed some differences in
cause compositions of neonatal deaths, particularly in
Zimbabwe compared to the other two settings. In Zim-
babwe, the proportions of preterm births and deaths
due to infection were higher (44%) than in Malawi
(28%) or Nepal (20%).
Discussion
The deadline for the Millennium Development Goals
(MDGs) is less than five years away and the need to
quantify childhood mortality, understand its causes, and
assess the effects of proposed interventions are central
to MDG4. Neonatal deaths contribute about 40% of
under-5 mortality globally [24]. A recent evaluation of
the INDEPTH network of Health and Demographic Sur-
veillance Sites [25] calls for all sites to use InterVA for
coding of causes of death, since such approaches repre-
sent “the only viable strategy to produce timely and
comparable cause of death statistics” [26]. Our study has
revised the InterVA method for verbal autopsy to
improve its ability to identify causes of stillbirth and
newborn death and tested it in three populations.
In this study, physician review was used as a reference
standard to compare InterVA. The use of physician
review was the only alternative source of cause of death
assessment for our study populations. This choice has
limitations, however. Physicians are influenced by their
experience, perception, and interpretation of local epide-
miology [23,27]. Moreover, they mostly use the open
history to reach a decision and may not account consis-
tently for all the indicators. Sensitivity and specificity of
physician review compared with hospital diagnosis in
neonatal populations varied between 64% and 74% in a
recent study [20] and concerns about inter- and intrara-
ter reliability are well described [23].
An alternative to physician diagnoses is the use of
hospital records. Hospital diagnoses have been used to
establish sensitive, specific, and positive predictive values
of VA diagnoses [8,12,20]. The main pitfall of hospital
diagnoses in developing countries, particularly in rural
settings, is that the CSMF of deaths occurring in hospi-
tals are likely to be different from the ones in commu-
nities [23]. There is therefore the risk of increasing
precision of an interpretative method, defined as its abil-
ity to reproduce hospital diagnoses in the population
where it is tested. This would not necessarily produce
results that are correct when used in populations where
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the ability to recognize, recall, and report signs of ill-
nesses may be different among hospital users and non-
hospital users.
The results of InterVA as compared with physician
review showed an almost identical ranking of causes of
death. However, differences exist. Some of these differ-
ences can be explained by the way the model was con-
structed. Prematurity, for example, was over-diagnosed
by InterVA in Zimbabwe and Nepal. This probably
resulted from using a dataset where clinicians were
allowed more than a single cause of death to refine
InterVA. In fact, when multiple causes of death are
allowed, prematurity is more likely to be listed as a
coexisting cause of death t h a nw h e nas i n g l ec a u s ei s
selected [28]. The model did not include “other” as a
cause of death and would have classified such causes of
death in one of the available diagnoses.
InterVA over-diagnosed neonatal infections compared
with physician review in Zimbabwe, while the opposite
happened in Nepal. This inconsistency could be due to
the interpretation of signs by different physicians.
Alternatively, it could be due to the selection of a priori
probabilities. Greater understanding of the way physi-
cians decide to value or ignore signs and symptoms may
help in future refinements and evaluations of InterVA.
Stillbirths were included for practical and public
health reasons. Although globally there are about 3.2
million stillbirths per year, reliable statistics are lacking
[29]. This information gap has to be addressed. About
half of perinatal deaths are accounted for by stillbirths
[29]. The refinements including stillbirths in the model
eliminate the need to differentiate between live births
and stillbirths before processing VA data, making the
method more suitable for use in large surveys. The
separation between fresh and macerated stillbirths is
relevant, as prevention strategies are different. The com-
parisons between InterVA and physician review in
Malawi and Nepal suggest that InterVA can differentiate
the two categories, although, as with neonatal deaths,
there may be room for further refinement.
Case-by-case agreement was moderate in all datasets,
however it was lower for Zimbabwe compared to Nepal
and Malawi. The new indicators and matrix probabilities
have been chosen and modified on the basis of the per-
sonal experience of the researchers, and subsequently
tested and modeled on a subset of the Malawi data.
There is a risk, therefore, that the tool may be too clo-
sely modeled on a sub-Saharan African setting (although
the results from Nepal do not support this) or on a
Malawi -100
0
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20
30
40
50
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I ndeterminate Congenital
malformation
Stillbirth Perinatal
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Neonatal
infections
Prematurity Other
InterVA
PR
Figure 1 Cause-specific mortality fractions from InterVA and
physician review (PR) for the 100 VA cases from Malawi used
to develop and refine the model. Note to Figure 1: Other causes
include “jaundice,”“ multiple pregnancies,”“ maternal causes,”
“hypothermia,” and “hypoglycemia.”
Table 3 Comparison of cause-specific mortality fractions according to InterVA and physician review
Malawi
69 VA
Nepal
385 VA
Zimbabwe
180 VA
Physician
review
InterVA Physician
review
InterVA Physician
review
InterVA
Stillbirth 28.0 44.3 44.0 45.2 16.5 20.1
Perinatal asphyxia 18.8 19.4 21.5 26.4 11.3 9.9
Neonatal infections 23.3 26.0 28.0 20.4 30.6 44.5
Prematurity 10.4 7.5 3.1 6.5 18.2 23.9
Congenital malformations 2.2 1.3 0.8 0.9 1.3 0.4
Other 13.3 1.6 9.5
Indeterminate 4.0 1.5 1.0 0.6 12.8 1.3
Table 4 Fresh/macerated split of stillbirths from Malawi
and Nepal based on interpretation by InterVA and
physician review
Malawi
169 VA
Nepal
385 VA
Physician
review
InterVA Physician
review
InterVA
Fresh 23.2 33.4 24.7 39.4
Macerated 4.8 10.9 19.2 5.9
Total Stillbirth 28.0 44.3 44.0 45.2
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have so far not been put to a panel of experts and may
need to be subject to a wider consensus.
There may be important epidemiological and social
explanations for the difference in the CSMF in Malawi,
Zimbabwe, and Nepal. However, even if the interpreta-
tion of verbal autopsy data by InterVA was consistent,
methodological variability in other aspects of VA may
have contributed to the observed cause distribution.
Indeed, the close comparability of CSMF between
Malawi and Nepal may to some degree reflect common
data capture processes that differ from those used in
Zimbabwe. It is possible that in Nepal and Malawi, the
populations were part of research areas and might have
been sensitized to recognize, describe, and recall signs
of neonatal diseases, while in Zimbabwe the community
was part of a government surveillance and may have
responded differently. Nevertheless, this is a reality of all
VA studies conducted in research settings. Use of lay (in
Malawi and Nepal) versus health-professional (in Zim-
babwe) interviewers and their gender may also have had
an impact on data capture. This highlights the need for
further methodological research into the effects of other
aspects of VA. It is likely that a number of strategies
and international collaborations will be necessary to
ensure the success of such investigations.
The modified version of InterVA for stillbirths and
neonatal deaths produced plausible results when com-
pared with physicians’ opinions but had the advantage
of being completely internally consistent, allowing stan-
dardized comparisons of data from different countries.
Ultimately, standardized methods are essential and their
application and evaluation in a wide range of settings is
encouraged. Through wider application, the strengths
and weakness of InterVA, and VA in general, will
become more apparent, thereby better informing the
application and public health utility of surrogate meth-
ods for measuring mortality in absence of vital registra-
tion systems.
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